Related Experiment Video
Updated: Apr 12, 2026
14:51
Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
Published on: June 17, 2022
3.7K
Insights
Mutations in the PRPS1 enzyme, crucial for purine synthesis, cause resistance to thiopurine drugs in relapsed acute lymphoblastic leukemia (ALL). This finding offers new insights into treatment strategies for ALL patients.
Area of Science:
- Biochemistry
- Oncology
- Pharmacology
Background:
- Acute lymphoblastic leukemia (ALL) is a common blood cancer.
- Thiopurines are a class of chemotherapy drugs used to treat ALL.
- Mechanisms of thiopurine resistance in relapsed ALL are not fully understood.
Purpose of the Study:
- To investigate the role of the de novo purine biosynthesis pathway in thiopurine resistance.
- To identify specific genetic mutations associated with treatment failure in relapsed ALL.
Main Methods:
- Analysis of genetic mutations in patients with relapsed ALL.
- Functional assays to assess the impact of PRPS1 mutations on purine biosynthesis.
- In vitro studies to evaluate thiopurine drug sensitivity in cells with PRPS1 mutations.
Main Results:
- Mutations in the phosphoribosyl pyrophosphate synthetase 1 (PRPS1) gene were identified in a subset of relapsed ALL patients.
- These PRPS1 mutations led to altered enzyme activity, affecting de novo purine biosynthesis.
- Cells with PRPS1 mutations exhibited significantly reduced sensitivity to thiopurine drugs.
Conclusions:
- Mutations in PRPS1 are a key driver of thiopurine resistance in relapsed ALL.
- Targeting PRPS1 or its pathway may represent a novel therapeutic strategy for overcoming thiopurine resistance.
- Understanding PRPS1's role can guide personalized treatment approaches for ALL.
Abstract:
Mutations in the de novo purine biosynthesis enzyme PRPS1 drive thiopurine resistance in relapsed ALL.
Related Concept Videos
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
74
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
74
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
69
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
69
02:23Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
02:56Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
01:28Biosynthesis of Nucleic Acids
1.6K
Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
1.6K
01:20The Retinoblastoma Gene
5.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
5.0K